Data as of Jan 27
| +0.06 / +0.68%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 29.00 and a low estimate of 19.00. The median estimate represents a +123.71% increase from the last price of 8.94.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.